Cofactor Genomics
PrivateLast Round
Strategic
Dec 15, 2025
Total Funding Raised
$29.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cofactor Genomics is a biotechnology company that develops predictive diagnostic tests for immunotherapy using RNA-expression models and machine learning to characterize tumor microenvironments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cofactor Genomics Comparables
Compare Cofactor Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novigenix AI | 84% | |
| GeneCentric | 83% | |
| Genomic Expression, Inc. | 80% |
Cofactor Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 15, 2025 | ||||
| Seed | Aug 2, 2023 | ||||
| Series A Extension | Dec 16, 2021 | ||||
| Series A | Sep 18, 2017 | ||||
| Seed | Aug 3, 2015 | ||||
Accelerator | Jul 31, 2015 |
Key People
Founding team and executive leadership
Cofactor Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| National Institute of Mental Health | Grant |
| iSelect Fund | Series A |
| Great Oaks Venture Capital | Seed |
| Founder Collective | Seed |
| Anorak Ventures | Seed |
| Khosla Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 33% MoM, reaching 3.6K.
- May 30, 2025
Presented on RNA and AI for Precision Medicine at the RNA Society's 30th Annual Meeting.
Cofactor Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cofactor Genomics's valuation, stock price, and market status.
Is Cofactor Genomics a public or private company?
Cofactor Genomics is a private company.
What is the current stock price of Cofactor Genomics?
Cofactor Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Cofactor Genomics worth (valuation)?
Valuation information for Cofactor Genomics is not publicly available.
Can I buy Cofactor Genomics stock?
Cofactor Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cofactor Genomics's last funding round?
Cofactor Genomics's most recent funding round was Series A Extension on December 16, 2021.
Who are the main investors in Cofactor Genomics?
Key investors in Cofactor Genomics include Menlo Ventures.
Will Cofactor Genomics IPO soon?
No public IPO plans have been announced for Cofactor Genomics.
How can I track Cofactor Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cofactor Genomics's secondary market activity and sign up for updates.